Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer.
Autor: | Wadhwa, Vivek K.1, Weston, Robin1, Parr, Nigel J.1 |
---|---|
Zdroj: | BJU International. Jun2011, Vol. 107 Issue 12, p1923-1929. 7p. 3 Charts, 3 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |